About

Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH

Intensive competition, a large und constant capacity for innovation, and at the same time a high degree of regulation: this is the challenging context confronting the life sciences and healthcare sector. Binder Grösswang’s expertise in dealing with the complex legal issues that can arise in this sector has been accrued over many years.


Particularly when operating in such a complex environment, excellent legal advice is essential in order to successfully meet the challenges of the market and take the best possible advantage of the opportunities that emerge. Therefore, Binder Grösswang’s multidisciplinary life sciences team is composed of experts from the entire spectrum of practice areas: from M&A through regulatory, finance, tax and competition law to intellectual property law. This enables us to address the needs of our clients through comprehensive, interdisciplinary counsel.


We support companies and their investors from the entire sector, including the fields of pharmaceuticals, medical technology, biotechnology, diagnostics and healthcare. We advise numerous clients – from start-ups to multinational groups – on a wide range of complex issues, focussing on legally sound, economically resilient solutions.


Members

Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH

Andreas Hable

Christian Zwick

Johannes Barbist

Regina Kröll

Clients

Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH

Agfa HealthCare

Alexion Pharmaceutical Inc

Asahi Kasei

Corza Health

Jazz Pharmaceuticals

Johnson & Johnson

Medicus AI

Novartis Sandoz

Portola Pharmaceuticals Inc.

SeneCura

Thermo Fisher Scientific

UNIQA

Vertellus

Industries

Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH

Food sector

Insurance companies

Pharmaceuticals

Start-ups